These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 7747469)

  • 21. Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae.
    Morin PJ; Downs JA; Snodgrass AM; Gilmore TD
    Cell Growth Differ; 1995 Jul; 6(7):789-98. PubMed ID: 7547500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concerted activity of host cell factor subregions in promoting stable VP16 complex assembly and preventing interference by the acidic activation domain.
    LaBoissière S; Walker S; O'Hare P
    Mol Cell Biol; 1997 Dec; 17(12):7108-18. PubMed ID: 9372942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in a yeast protein resembling HIV Tat-binding protein relieve requirement for an acidic activation domain in GAL4.
    Swaffield JC; Bromberg JF; Johnston SA
    Nature; 1992 Jun; 357(6380):698-700. PubMed ID: 1614516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PDX-1 activation domain provides specific functions necessary for transcriptional stimulation in pancreatic beta-cells.
    Peshavaria M; Cissell MA; Henderson E; Petersen HV; Stein R
    Mol Endocrinol; 2000 Dec; 14(12):1907-17. PubMed ID: 11117522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuroendocrine protein 7B2 contains unusually potent transcriptional activating sequences.
    Chaudhuri B; Huijbregts RP; Coen JJ; Fürst P
    Biochem Biophys Res Commun; 1995 Nov; 216(1):1-10. PubMed ID: 7488073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA recognition by the herpes simplex virus transactivator VP16: a novel DNA-binding structure.
    Babb R; Huang CC; Aufiero DJ; Herr W
    Mol Cell Biol; 2001 Jul; 21(14):4700-12. PubMed ID: 11416146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional activation by human c-myb and v-myb genes.
    Kalkbrenner F; Guehmann S; Moelling K
    Oncogene; 1990 May; 5(5):657-61. PubMed ID: 2189102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID.
    Stringer KF; Ingles CJ; Greenblatt J
    Nature; 1990 Jun; 345(6278):783-6. PubMed ID: 2193231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain.
    Stern S; Herr W
    Genes Dev; 1991 Dec; 5(12B):2555-66. PubMed ID: 1684335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation domains for controlling plant gene expression using designed transcription factors.
    Li J; Blue R; Zeitler B; Strange TL; Pearl JR; Huizinga DH; Evans S; Gregory PD; Urnov FD; Petolino JF
    Plant Biotechnol J; 2013 Aug; 11(6):671-80. PubMed ID: 23521778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transactivator proteins VP16 and GAL4 bind replication factor A.
    He Z; Brinton BT; Greenblatt J; Hassell JA; Ingles CJ
    Cell; 1993 Jun; 73(6):1223-32. PubMed ID: 8513504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The herpesvirus transactivator VP16 mimics a human basic domain leucine zipper protein, luman, in its interaction with HCF.
    Lu R; Yang P; Padmakumar S; Misra V
    J Virol; 1998 Aug; 72(8):6291-7. PubMed ID: 9658067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides.
    Wu TJ; Monokian G; Mark DF; Wobbe CR
    Mol Cell Biol; 1994 May; 14(5):3484-93. PubMed ID: 8164693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain.
    Lai JS; Cleary MA; Herr W
    Genes Dev; 1992 Nov; 6(11):2058-65. PubMed ID: 1358756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the DNA binding and transcriptional activation properties of the Ets1 oncoprotein.
    Gegonne A; Punyammalee B; Rabault B; Bosselut R; Seneca S; Crabeel M; Ghysdael J
    New Biol; 1992 May; 4(5):512-9. PubMed ID: 1515415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weak transcriptional activation is sufficient for transformation by v-Myb.
    Engelke U; Whittaker L; Lipsick JS
    Virology; 1995 Apr; 208(2):467-77. PubMed ID: 7747419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA.
    Lai JS; Herr W
    Mol Cell Biol; 1997 Jul; 17(7):3937-46. PubMed ID: 9199328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acidic transcriptional activation domains of herpes virus VP16 and yeast HAP4 have different co-factor requirements.
    Wang L; Turcotte B; Guarente L; Berger SL
    Gene; 1995 Jun; 158(2):163-70. PubMed ID: 7607537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation by TFIIB mutants that are severely impaired in interaction with promoter DNA and acidic activation domains.
    Chou S; Struhl K
    Mol Cell Biol; 1997 Dec; 17(12):6794-802. PubMed ID: 9372910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.